Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05930496 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors

StatusTerminated
PhaseNot applicable
Started2025-07-08
View on ClinicalTrials.gov ↗
This trial evaluates the effects a moderate-to-vigorous exercise intervention has on the bacterial make-up of the gastrointestinal tract (gut microbiota) in survivors of stage II-III colorectal cancer (CRC). Data shows that the gut microbiota composition and function may be drivers of CRC. High levels of exercise are associated with improved CRC prognosis and survival. While data suggests that exercise has the potential to influence gut microbiota composition and function, it is not known whether these effects contribute to improved CRC prognosis. This clinical trial evaluates the effects an exercise intervention has on gut microbiota and how these effects relate to CRC progression and patient-reported outcomes.

Amendment history 3 changes detected by DataLookout

2026-09-03
critical
Trial terminated: Terminated due to low accrual.
2026-09-03
minor
Final enrollment: 10 participants (planned 30)
2026-09-03
minor
Primary completion confirmed: June 2026 (last estimated January 2027)
Trial Details
NCT Number NCT05930496
Lead Sponsor Fred Hutchinson Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8, Colorectal Carcinoma
Enrollment 10 participants
Start Date 2025-07-08
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-09-02